{"gene":"IL21","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":2007,"finding":"IL-21 is produced by Th17 cells and acts as an autocrine cytokine sufficient and necessary for Th17 differentiation. IL-6 induces IL-21 in activated T cells via STAT3 (but not ROR-γ). IL-21 in turn potently induces Th17 differentiation and suppresses Foxp3 expression, requiring both STAT3 and ROR-γ (Rorc). IL-21 deficiency impairs Th17 generation and protects against experimental autoimmune encephalomyelitis.","method":"Genetic knockout (IL-21-deficient mice), cytokine stimulation assays, STAT3/ROR-γ pathway analysis, EAE model","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype, multiple orthogonal methods including genetic rescue and in vivo disease model","pmids":["17581589"],"is_preprint":false},{"year":2010,"finding":"IL-21 signaling acts directly on B cells (B cell-intrinsic) to maintain Bcl-6 expression in germinal center B cells, regulate GC persistence and proliferation, promote plasma cell and memory B cell formation, and support affinity maturation. CD3-expressing cells are the source of IL-21 acting on B cells in vivo.","method":"Bone marrow chimeras with IL-21R-deficient and wild-type cells, protein antigen immunization, flow cytometry, gene expression analysis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — bone marrow chimera epistasis definitively placing IL-21 action on B cells, multiple orthogonal readouts including affinity maturation and Bcl-6 expression","pmids":["20142430"],"is_preprint":false},{"year":2010,"finding":"IL-21-induced B cell differentiation into plasma cells in humans requires B cell-intrinsic STAT3 signaling. STAT3 loss-of-function mutations abolish IL-21-driven naive B cell differentiation into plasma cells and reduce antigen-specific memory B cells. STAT1 deficiency has no effect on IL-21-induced immunoglobulin secretion in vitro.","method":"Studies of patients with inactivating STAT1 or STAT3 mutations, in vitro IL-21 stimulation assays, immunoglobulin secretion measurement","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — human loss-of-function mutations with defined cellular phenotype, two orthogonal patient cohorts, replicated by multiple methods","pmids":["20048285"],"is_preprint":false},{"year":2008,"finding":"IL-21 induces its own expression in human T cells via an autocrine loop: IL-21 activates STAT3, which is recruited to the IL-21 gene promoter to enhance IL-21 transcription. Pharmacological inhibition or siRNA knockdown of STAT3 prevents IL-21 auto-induction.","method":"STAT3 inhibition, siRNA knockdown, promoter ChIP assay, cytokine stimulation of human peripheral blood and lamina propria T cells","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP demonstrating STAT3 binding to IL-21 promoter plus siRNA knockdown with functional readout, single lab but multiple orthogonal methods","pmids":["18209077"],"is_preprint":false},{"year":2013,"finding":"Loss-of-function mutations in IL21R cause primary immunodeficiency. The IL-21R Arg201Leu mutation causes aberrant trafficking of IL-21R to the plasma membrane, abrogates IL-21 ligand binding, and leads to defective phosphorylation of STAT1, STAT3, and STAT5, resulting in impaired B cell proliferation, immunoglobulin class-switching, T cell cytokine production, and NK cell cytotoxicity.","method":"Exome sequencing, candidate gene sequencing, receptor trafficking assays, IL-21 ligand binding assays, STAT phosphorylation assays, functional lymphocyte assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — human loss-of-function mutations with mechanistic characterization of receptor trafficking and signaling defects using multiple methods","pmids":["23440042"],"is_preprint":false},{"year":2006,"finding":"IL-21 down-regulates NKG2D surface expression on human NK and CD8+ T cells by dramatically reducing DAP10 promoter activity, thereby attenuating NKG2D-mediated NK cell cytotoxicity and degranulation. Conversely, IL-21 induces expression of NK activation receptors NKp30 and 2B4, and costimulatory receptor CD28 on CD8+ T cells.","method":"Cell culture with human primary NK and CD8+ T cells, NKG2D redirected lysis assays, degranulation assays, DAP10 luciferase reporter construct, transcript analysis","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — luciferase reporter (Tier 1) plus functional cytotoxicity assays and transcript analysis, single lab with multiple orthogonal methods","pmids":["16424177"],"is_preprint":false},{"year":2006,"finding":"The IL-21 receptor augments Th2 effector function and alternative macrophage activation in vivo. IL-21 significantly augments IL-4Rα and IL-13Rα1 expression in macrophages, resulting in increased FIZZ1 mRNA and arginase-1 activity following IL-4 and IL-13 stimulation. IL-21R deficiency reduces granulomatous inflammation, liver fibrosis, and Th2 cytokine responses to helminth infection.","method":"IL-21R-knockout mice infected with Schistosoma mansoni and Nippostrongylus brasiliensis, soluble IL-21R-Fc blockade, in vitro macrophage stimulation assays","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO with defined cellular phenotype in two parasite infection models, plus in vitro mechanistic receptor upregulation data","pmids":["16778988"],"is_preprint":false},{"year":2008,"finding":"IL-21 signaling through IL-21R is critical for the development of type 1 diabetes in the NOD mouse. IL-21R-knockout NOD mice are devoid of pancreatic lymphocytic infiltration and are protected from diabetes. This correlates with reduced Th17 cells and significantly higher expression of Reg family genes whose products protect against diabetes.","method":"IL-21R KO backcrossed to NOD mice, glucose monitoring, histological analysis, T cell and Treg functional assays, Reg gene mRNA quantification","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO with defined in vivo phenotype in autoimmune disease model, multiple mechanistic readouts","pmids":["18779574"],"is_preprint":false},{"year":2010,"finding":"The NF-κB transcription factor c-Rel is required for IL-21 gene expression in T lymphocytes. c-Rel binds a specific site in the proximal il21 promoter, confirmed in vitro and in vivo by ChIP. IL-21 mRNA and protein are reduced in CD4+ T cells from rel−/− mice. Administration of IL-21 protein rescues Tfh cell development but not germinal center B cell development in rel−/− mice.","method":"c-Rel KO mice, ChIP assay for c-Rel promoter binding, IL-21 rescue experiments, flow cytometry of T and B cell populations","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP demonstrating direct c-Rel binding to il21 promoter, KO phenotype with in vivo IL-21 rescue, single lab with multiple methods","pmids":["20639489"],"is_preprint":false},{"year":2015,"finding":"STAT1 and STAT3 have opposing roles in IL-21 signaling in CD4+ T cells. IL-21 activates both STAT1 and STAT3; STAT1 phosphorylation is augmented in Stat3-deficient CD4+ T cells. RNA-Seq in Stat1- and Stat3-deficient mice shows both are critical for IL-21-mediated gene regulation. STAT1 and STAT3 differentially regulate Tbx21 and Ifng expression, with opposing in vivo roles during chronic LCMV infection.","method":"Stat1- and Stat3-deficient mice, RNA-Seq, phosphorylation assays, chronic LCMV infection model, patient samples (STAT3-deficient/STAT1 gain-of-function patients)","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Strong — RNA-Seq with KO mouse models, validated in vivo and in human primary cells with distinct genetic defects, multiple orthogonal methods","pmids":["26170288"],"is_preprint":false},{"year":2013,"finding":"IL-21 directly inhibits Treg cell expansion in a cell-intrinsic manner during chronic LCMV infection. In IL-21R−/− mice, virus-driven Treg cell expansion is greatly enhanced. IL-21 restricts Treg proliferation, and augmented Treg expansion (via IL-2/anti-IL-2 immune complexes) impairs antiviral T cell responses and promotes viral persistence.","method":"IL-21R KO mice, LCMV infection model, Treg depletion, IL-2/anti-IL-2 complex administration, flow cytometry of CD8+ T cell function","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO with defined in vivo phenotype, multiple epistatic experiments, cell-intrinsic mechanism established","pmids":["23696736"],"is_preprint":false},{"year":2016,"finding":"IL-21 promotes CD8+ T cell stemness and stem cell memory T cell (TSCM) formation through maintaining metabolic quiescence dependent on oxidative phosphorylation, in contrast to IL-2 which drives aerobic glycolysis via LDH induction. LDH inhibition combined with IL-21 synergistically increases TSCM formation and antitumor responses.","method":"Metabolic profiling (OXPHOS vs glycolysis), LDH inhibition, Ldha gene deletion, adoptive transfer tumor models, transcriptomic analysis","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic deletion of Ldha, metabolic profiling, adoptive transfer functional validation, multiple orthogonal methods in single study","pmids":["32123114"],"is_preprint":false},{"year":2019,"finding":"IL-21 directly promotes apoptosis of Foxp3+ regulatory T cells by interfering with Bcl-2 family gene expression, thereby indirectly sustaining generation of inflammatory TH cells and TH2-driven asthmatic responses. This cell-intrinsic effect was demonstrated using mixed bone marrow chimeras and competitive adoptive transfer experiments.","method":"IL-21R-deficient mice, mixed bone marrow chimeras, adoptive transfer of Treg cells, Treg depletion experiments, in vitro apoptosis assays with Bcl-2 family gene analysis","journal":"The Journal of allergy and clinical immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — mixed chimeras and competitive transfers establishing cell-intrinsic mechanism, Bcl-2 family molecular mechanism, multiple orthogonal models","pmids":["30654048"],"is_preprint":false},{"year":2013,"finding":"CD40L combined with IL-21 is sufficient to induce robust proliferation of CLL cells, defining an IL-21-induced gene signature containing JAK/STAT and apoptosis pathway components. IL-21 production by CD4+CXCR5+ follicular helper T cells was detected in lymph nodes, where IL-21 RNA and protein were also found.","method":"Co-culture of CLL cells with autologous T cells or recombinant CD40L+IL-21, gene expression profiling, in situ detection of IL-21 in lymph node samples, ELISA","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined minimal signal (CD40L+IL-21) sufficient for CLL proliferation, gene signature validated in patient LN samples, single lab","pmids":["24014238"],"is_preprint":false},{"year":2004,"finding":"IFN-α/β enhances IL-21 mRNA expression in activated human T cells and an IFN-γ activation site (GAS) element in the IL-21 promoter binds STAT1, STAT2, STAT3, and STAT4 in IFN-α/β-stimulated NK or T cell extracts. Conversely, IFN-α/β down-regulates IL-21R expression in NK and T cells, resulting in reduced STAT3 phosphorylation and DNA binding after IL-21 stimulation.","method":"Promoter analysis with gel shift (EMSA), mRNA expression analysis, STAT3 phosphorylation assays in human NK and T cells","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA demonstrating STAT factor binding to IL-21 promoter GAS element, functional signaling readout, single lab","pmids":["15178704"],"is_preprint":false},{"year":2016,"finding":"IL-21 enhances NK cell signal transduction via activation of ERK and STAT1 when responding to cetuximab-coated pancreatic tumor cells, and increases NK cell-mediated ADCC, IFN-γ secretion, and T cell chemotaxis. In vivo, mIL-21 combined with cetuximab significantly inhibits tumor growth in pancreatic cancer xenograft models.","method":"NK cell activation assays (ADCC, IFN-γ ELISA), ERK/STAT1 phosphorylation analysis, subcutaneous and intraperitoneal xenograft models","journal":"Clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined signaling mechanism (ERK/STAT1) with functional validation in vitro and in vivo, single lab","pmids":["27435400"],"is_preprint":false},{"year":2015,"finding":"Bruton's tyrosine kinase (Btk) amplifies IL-21 signaling in human B cells by mediating nuclear (but not cytoplasmic) STAT1 phosphorylation downstream of IL-21 combined with BCR and CD40 signals. Btk inhibition suppresses IL-21-induced B cell differentiation and IgG production.","method":"Btk inhibitor treatment, phosphorylation assays distinguishing nuclear vs cytoplasmic STAT1, BJAB cell line signaling assays, flow cytometry, ELISA","journal":"Rheumatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined nuclear STAT1 phosphorylation as Btk-dependent downstream of IL-21, pharmacological and subcellular fractionation evidence, single lab","pmids":["25724205"],"is_preprint":false},{"year":2017,"finding":"IL-4 and IL-21 cooperate to maintain high Bcl-6 protein levels required for germinal center formation. IL-21 prevents BCR-mediated proteasomal degradation of Bcl-6. Combined B cell-intrinsic loss of IL-4 and IL-21 signaling almost completely eliminates the GC response in vivo.","method":"Bcl-6 protein stability assays in stimulated B cells, conditional KO mice for IL-4R and IL-21R signaling, flow cytometry of GC populations","journal":"Immunology and cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — protein stability mechanistic assay plus in vivo KO epistasis, single lab with orthogonal methods","pmids":["28875978"],"is_preprint":false},{"year":2013,"finding":"NR4A2 (nuclear receptor) controls full Th17 differentiation via autocrine IL-21 signaling. When NR4A2 expression is blocked by siRNA, Th17 cells express RORγt but fail to produce IL-17 and IL-21, and this differentiation defect is rescued by exogenous IL-21. In vivo NR4A2 siRNA treatment reduces Th17 effector responses and protects against EAE.","method":"siRNA knockdown of NR4A2 in vitro, exogenous IL-21 rescue experiment, in vivo siRNA treatment, EAE model, flow cytometry","journal":"PLoS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA KD with IL-21 rescue establishing epistatic relationship, in vivo confirmation, single lab","pmids":["23437182"],"is_preprint":false},{"year":2009,"finding":"IL-21 induces apoptosis of follicular lymphoma cells (carrying t(14;18)) via caspase-8 and caspase-3 activation, reduction of mitochondrial membrane potential, decreased Bcl-2 expression, and increased Bax expression. In contrast, IL-21 stimulates growth of Burkitt lymphoma and T cell leukemia lines.","method":"In vitro IL-21 treatment of lymphoma cell lines, caspase activity assays, mitochondrial membrane potential measurement, Bcl-2/Bax protein expression","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple mechanistic apoptosis assays in cell lines, single lab, consistent results across methods","pmids":["17624663"],"is_preprint":false},{"year":2009,"finding":"IL-21 contributes to JAK3/STAT3 activation and cell growth in ALK+ anaplastic large cell lymphoma. Recombinant IL-21 enhances JAK3/STAT3 activation and increases cell growth; siRNA knockdown of IL-21R decreases STAT3 activation and cell growth. IL-21R expression is independent of NPM-ALK.","method":"Recombinant IL-21 treatment, IL-21R siRNA knockdown, JAK3/STAT3 phosphorylation assays, cell growth assays, NPM-ALK overexpression/knockdown","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with defined signaling readout, reciprocal gain/loss approach, single lab","pmids":["19608866"],"is_preprint":false},{"year":2016,"finding":"IL-21 enhances IL-21 gene expression through a long-range chromatin interaction mechanism. A conserved noncoding sequence 49 kb upstream of IL-21 acts as an enhancer in a STAT3- and NFAT-dependent manner. IL-6/STAT3 signaling induces dynamic chromatin looping between the IL-21 promoter and distal enhancer. This interaction is absent in regulatory T cells where IL-21 expression is repressed.","method":"Chromosome conformation capture (3C/4C), ChIP for STAT3 and NFAT, CTCF binding assays, enhancer reporter assays, naive vs regulatory T cell comparisons","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — chromatin conformation capture plus ChIP demonstrating STAT3 binding and enhancer activity, multiple orthogonal epigenomic methods in single study","pmids":["27067007"],"is_preprint":false},{"year":2018,"finding":"SUMO-defective c-Maf preferentially transactivates Il21 by selectively inhibiting recruitment of the Daxx/HDAC2 repressor complex to the Il21 promoter and enhancing histone acetylation via CBP and p300. This epigenetic mechanism promotes extrafollicular helper T cell development and IL-21-mediated diabetogenesis in NOD mice.","method":"Transgenic NOD mice with WT or SUMOylation-mutant c-Maf, ChIP for Daxx/HDAC2 and histone acetylation at Il21 promoter, CBP/p300 inhibitor (CBP30) treatment, diabetes incidence monitoring","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP demonstrating chromatin mechanism at Il21 promoter, transgenic mouse epistasis, pharmacological validation, single lab with multiple orthogonal methods","pmids":["30059018"],"is_preprint":false},{"year":2019,"finding":"The orphan nuclear receptor NR2F6 directly binds the IL-21 promoter and a conserved noncoding sequence near the Il21 gene in resting CD4+ T cells to repress IL-21 transcription. During Tfh cell differentiation, this NR2F6 DNA interaction is abolished, allowing Il21 expression. Enhanced Tfh cell accumulation in Nr2f6-deficient mice is reversed by blocking IL-21R signaling.","method":"ChIP demonstrating NR2F6 binding to IL-21 promoter and CNS, Nr2f6-deficient mice, IL-21R blockade rescue experiment, flow cytometry","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP demonstrating direct transcription factor binding to IL-21 regulatory elements, KO mouse with genetic rescue by IL-21R blockade, single lab with multiple methods","pmids":["31509749"],"is_preprint":false},{"year":2023,"finding":"Heparan sulfate (HS) regulates IL-21 bioavailability and signal strength in germinal center B cells. N-deacetylase and N-sulfotransferase 1 (Ndst1)-mediated N-sulfation of HS in B cells promotes IL-21 binding and signaling. GC B cells have reduced HS sulfation compared to non-GC cells, attenuating IL-21 signaling. Ndst1 is down-regulated in GC B cells and up-regulated in ASC precursors, enabling selective desensitization to IL-21 in the GC and strong signaling in ASC differentiation.","method":"IL-21 binding assays on GC vs non-GC B cells, Ndst1-deficient B cell analysis, HS sulfation biochemical assays, in vivo GC and ASC differentiation analysis","journal":"Science immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — biochemical characterization of HS modification controlling IL-21 binding, genetic KO of Ndst1, in vivo functional validation, single study with multiple orthogonal methods","pmids":["36800411"],"is_preprint":false},{"year":2022,"finding":"IL-21 acts as a key regulator of the initial B cell response by accelerating cell cycle progression and rate of cycle entry, increasing B cell contribution to the germinal center. This effect occurs across a range of BCR affinities and correlates with elevated AKT and S6 phosphorylation. The increased proliferation mechanistically explains IL-21-mediated promotion of plasma cell differentiation.","method":"B cell transfer and immunization models with IL-21R-deficient and WT cells, cell cycle analysis, AKT and S6 phosphorylation assays, flow cytometry","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO epistasis with defined cell cycle and signaling mechanism, multiple orthogonal methods, single lab","pmids":["35801309"],"is_preprint":false},{"year":2023,"finding":"IL-21 shapes germinal center polarization by promoting selection of light zone GC B cells for dark zone entry and triggering cyclin D3 upregulation in GC B cells to tune inertial cell cycling. IL-21R deficiency results in smaller GC skewed toward light zone phenotype. Foxo1 regulation links IL-21 signaling to dark zone GC B cell formation.","method":"IL-21R-deficient mice, cyclin D3 expression analysis, GC B cell light/dark zone flow cytometric analysis, immunization-induced and spontaneous autoimmune GC models","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KO with defined molecular mechanism (cyclin D3, Foxo1) and cellular phenotype, multiple GC models, single lab with orthogonal methods","pmids":["37466652"],"is_preprint":false},{"year":2023,"finding":"IL-21 secreted by intrathyroidal TFH and TPH cells drives clonally expanded cytotoxic CXCR6+CD8+ T cells in ICI-thyroiditis. IL-21 treatment of human CD8+ T cells upregulates IFN-γ, granzyme B, and CXCR6. Genetic deletion of IL-21 signaling in mice protects from thyroid immune infiltration after ICI treatment.","method":"Single-cell RNA sequencing of thyroid specimens, in vitro CD8+ T cell stimulation with IL-21, IL-21 genetic KO mouse model of IRAEs, immunohistochemistry","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — scRNA-seq defining cell populations, in vitro mechanistic validation, in vivo genetic KO confirmation, orthogonal human and mouse data","pmids":["37196065"],"is_preprint":false},{"year":2023,"finding":"IL-21 induces pyroptosis of Treg cells via activation of the Akt-mTOR-NLRP3-caspase 1 signaling axis in eosinophilic chronic rhinosinusitis. Akt-mTOR inhibition prevents IL-21-induced pyroptosis in human and mouse Treg cells. Blocking IL-21/IL-21R signaling reduces eosinophil numbers and increases Treg cell percentage in ECRS mice.","method":"Western blot analysis of pyroptosis markers, electron microscopy of pyroptotic cells, Akt-mTOR inhibitor treatment, IL-21/IL-21R neutralization in mouse model, flow cytometry","journal":"The Journal of allergy and clinical immunology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — defined signaling pathway with inhibitor validation, morphological evidence of pyroptosis, in vivo neutralization model, multiple orthogonal methods","pmids":["37164271"],"is_preprint":false},{"year":2015,"finding":"IL-21 promotes intestinal IgA class switch recombination and IgA production through TGFβ1-dependent mechanisms. IL-21 combined with retinoic acid induces IgA+ B cell development and drives autocrine TGFβ1 production to initiate IgA CSR. IL-21 also promotes intestinal B cell homing through α4β7 expression.","method":"Il17- and Il21-deficient mice, T cell reconstitution of TCRβxδ−/− mice with antigen-specific Th17 cells, IL-21 neutralization, B cell IgA CSR assays","journal":"Mucosal immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with defined cellular mechanism, neutralization in T cell reconstitution model, single lab with multiple methods","pmids":["25586558"],"is_preprint":false},{"year":2020,"finding":"Histone deacetylase inhibitors (HDACi) combined with IL-21 reprogram differentiated human effector CD8+ T cells to central memory-like T cells. HDACi increases H3 acetylation and chromatin accessibility at the CD28 promoter, enabling IL-21-mediated pSTAT3 binding to the CD28 locus and subsequent upregulation of CD28 and CD62L. Reprogrammed cells show stable memory transcriptional signature (Lef1, Tcf7).","method":"ChIP for H3 acetylation and STAT3 binding at CD28 promoter (ATAC-seq for chromatin accessibility), flow cytometry for CD28/CD62L surface markers, functional proliferation assays","journal":"Cancer immunology research","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — ChIP and chromatin accessibility data establishing mechanism, pSTAT3 binding validation, single lab","pmids":["32213626"],"is_preprint":false}],"current_model":"IL-21 is a pleiotropic type I cytokine produced primarily by CD4+ T cells (including Tfh and Th17 cells) and NKT cells that signals through a heterodimeric IL-21R/γc receptor complex to activate JAK/STAT pathways (principally STAT3, with opposing regulatory input from STAT1), driving B cell germinal center reactions (via Bcl-6 maintenance, cyclin D3-dependent dark zone cycling, and heparan sulfate-regulated signal strength), plasma cell differentiation, Th17 cell development (as an autocrine amplifier via STAT3→IL-21→RORγt), NK cell maturation, and direct Treg apoptosis through Bcl-2 family suppression and Akt-mTOR-NLRP3-caspase 1 pyroptosis, while its own transcription is regulated by c-Rel binding to its proximal promoter, STAT3-dependent long-range chromatin looping, NR2F6-mediated repression, and c-Maf SUMOylation status controlling CBP/p300-mediated histone acetylation."},"narrative":{"mechanistic_narrative":"IL-21 is a pleiotropic CD4+ T cell-derived cytokine that orchestrates B cell humoral immunity, T cell effector and memory programs, and immune regulation, signaling through the IL-21R to activate JAK/STAT pathways [PMID:23440042, PMID:26170288]. Loss-of-function mutation in its receptor causes a primary immunodeficiency, with aberrant IL-21R trafficking abrogating ligand binding and defective STAT1/STAT3/STAT5 phosphorylation that impairs B cell proliferation, class-switching, T cell cytokine production, and NK cytotoxicity [PMID:23440042]. In B cells, IL-21 acts cell-intrinsically to maintain germinal center reactions: it sustains Bcl-6 expression by blocking BCR-driven proteasomal degradation (cooperatively with IL-4), accelerates cell cycle entry through AKT/S6 signaling, and tunes dark-zone selection via cyclin D3 and Foxo1, while human plasma cell differentiation requires B cell-intrinsic STAT3 [PMID:20142430, PMID:20048285, PMID:28875978, PMID:35801309, PMID:37466652]. The strength of this B cell signal is set extracellularly by heparan sulfate N-sulfation, which is downregulated in GC B cells to desensitize them and upregulated in antibody-secreting cell precursors [PMID:36800411]. In T cells, IL-21 is both an effector and a self-amplifying autocrine signal—IL-6/STAT3 induces IL-21, which feeds back via STAT3 recruitment to its promoter and STAT3/NFAT-dependent long-range enhancer looping to drive Th17 differentiation and suppress Foxp3 [PMID:17581589, PMID:18209077, PMID:27067007]. IL-21 also restrains regulatory T cells, directly limiting Treg expansion and triggering Treg death via Bcl-2 family suppression and an Akt-mTOR-NLRP3-caspase-1 pyroptosis axis, and promotes CD8+ T cell stemness through metabolic quiescence dependent on oxidative phosphorylation [PMID:23696736, PMID:30654048, PMID:37164271, PMID:32123114]. IL-21 transcription is gated by activating inputs (c-Rel and SUMO-state-dependent c-Maf controlling Daxx/HDAC2 versus CBP/p300 occupancy) and repressive inputs (NR2F6 binding that is released during Tfh differentiation) [PMID:20639489, PMID:30059018, PMID:31509749]. These activities make IL-21 a driver of autoimmune and inflammatory disease in models of EAE, type 1 diabetes, Th2/helminth pathology, and immune-checkpoint-induced thyroiditis [PMID:17581589, PMID:18779574, PMID:16778988, PMID:37196065].","teleology":[{"year":2004,"claim":"Established that IL-21 transcription is inducible by interferon signaling while IL-21R is reciprocally downregulated, defining an early layer of cross-cytokine control of the IL-21 axis.","evidence":"EMSA/promoter analysis and STAT3 phosphorylation in human NK and T cells","pmids":["15178704"],"confidence":"Medium","gaps":["GAS element occupancy shown by EMSA not chromatin-context ChIP","Functional consequence of receptor downregulation on B cell output not addressed"]},{"year":2006,"claim":"Showed IL-21 reshapes innate and Th2 effector function—suppressing NKG2D-dependent NK cytotoxicity via DAP10 while augmenting macrophage IL-4R/IL-13R responsiveness—broadening its role beyond adaptive immunity.","evidence":"DAP10 luciferase reporter and cytotoxicity/degranulation assays in human NK/CD8 cells; IL-21R-KO mice in helminth infection","pmids":["16424177","16778988"],"confidence":"High","gaps":["Direct transcription factors driving DAP10 repression not identified","Mechanism of IL-4R/IL-13R upregulation downstream of IL-21R unresolved"]},{"year":2007,"claim":"Identified IL-21 as an autocrine cytokine necessary and sufficient for Th17 differentiation, placing it downstream of IL-6/STAT3 and explaining its role in autoimmune EAE.","evidence":"IL-21-deficient mice, STAT3/RORγt pathway analysis, EAE model","pmids":["17581589"],"confidence":"High","gaps":["Did not resolve chromatin/promoter basis of IL-21 induction","Relative contribution of autocrine vs paracrine IL-21 in vivo not quantified"]},{"year":2008,"claim":"Defined the molecular basis of IL-21 self-amplification by showing STAT3 is recruited to the IL-21 promoter to drive an autocrine transcriptional loop in human T cells.","evidence":"Promoter ChIP, STAT3 inhibition and siRNA with cytokine readout in human T cells","pmids":["18209077"],"confidence":"High","gaps":["Distal regulatory elements not yet examined","Stoichiometry/kinetics of the feedback loop not defined"]},{"year":2008,"claim":"Demonstrated IL-21R signaling is required for type 1 diabetes pathogenesis, linking the cytokine to organ-specific autoimmunity via Th17 expansion and Reg gene suppression.","evidence":"IL-21R-KO NOD mice with glucose monitoring, histology, and Reg gene quantification","pmids":["18779574"],"confidence":"High","gaps":["Cellular target of IL-21 driving islet infiltration not isolated","Mechanism connecting IL-21 to Reg gene levels unresolved"]},{"year":2009,"claim":"Revealed context-dependent IL-21 effects on transformed lymphocytes—apoptosis in follicular lymphoma versus pro-growth JAK3/STAT3 signaling in ALK+ ALCL and Burkitt lines.","evidence":"Caspase/mitochondrial assays in lymphoma lines; recombinant IL-21 and IL-21R siRNA with JAK3/STAT3 readout","pmids":["17624663","19608866"],"confidence":"Medium","gaps":["Determinants of pro-apoptotic vs pro-growth outcome not defined","Cell-line findings not validated in primary tumors in these studies"]},{"year":2010,"claim":"Established IL-21 as a B cell-intrinsic regulator of the germinal center via Bcl-6 maintenance and showed human plasma cell differentiation strictly requires B cell-intrinsic STAT3.","evidence":"IL-21R-deficient bone marrow chimeras with immunization; human STAT1/STAT3 loss-of-function patient B cells","pmids":["20142430","20048285"],"confidence":"High","gaps":["How IL-21/STAT3 sustains Bcl-6 mechanistically not resolved here","STAT5 contribution to B cell program not addressed"]},{"year":2010,"claim":"Identified c-Rel as a direct transcriptional activator of IL-21 in T cells and dissociated IL-21's role in Tfh formation from GC B cell development by rescue.","evidence":"c-Rel KO mice, promoter ChIP, IL-21 protein rescue, flow cytometry","pmids":["20639489"],"confidence":"High","gaps":["Interplay of c-Rel with STAT3 at the locus not defined","Why IL-21 rescues Tfh but not GC B cells in rel-/- not explained"]},{"year":2013,"claim":"Showed IL-21 cell-intrinsically restrains Treg expansion and that this restraint is required for effective antiviral CD8 responses, framing IL-21 as a suppressor of immune regulation.","evidence":"IL-21R-KO mice in chronic LCMV with Treg depletion and IL-2 complex experiments","pmids":["23696736"],"confidence":"High","gaps":["Molecular mechanism limiting Treg proliferation not defined here","Direct vs indirect effect on CD8 responses not fully separated"]},{"year":2013,"claim":"Connected IL-21 to autoimmunity through SUMO-dependent c-Maf/NR4A2 regulatory inputs and to malignant B cell proliferation in CLL, expanding both transcriptional control and disease relevance.","evidence":"NR4A2 siRNA with IL-21 rescue and EAE; CD40L+IL-21 co-culture of CLL cells with gene signature and patient LN detection","pmids":["23437182","24014238"],"confidence":"Medium","gaps":["NR4A2 mechanism on IL-21 locus indirect","CLL signature causal drivers not dissected"]},{"year":2015,"claim":"Resolved that STAT1 and STAT3 exert opposing, non-redundant control of IL-21-driven gene programs in CD4+ T cells, including Tbx21/Ifng and in vivo antiviral outcomes.","evidence":"Stat1- and Stat3-deficient mice with RNA-Seq, chronic LCMV, and human patients with distinct STAT defects","pmids":["26170288"],"confidence":"High","gaps":["How STAT1/STAT3 balance is set per cell type unresolved","Direct target genes of each STAT not all mapped"]},{"year":2015,"claim":"Identified Btk as an amplifier of IL-21 signaling controlling nuclear STAT1 phosphorylation in B cells, and linked IL-21 to intestinal IgA via TGFβ1-dependent class switching.","evidence":"Btk inhibitor with subcellular STAT1 fractionation in B cell line; Il21-deficient mice and Th17 reconstitution for IgA CSR","pmids":["25724205","25586558"],"confidence":"Medium","gaps":["Btk's selectivity for nuclear vs cytoplasmic STAT1 mechanistically unclear","Direct vs autocrine-TGFβ1 contributions to IgA not fully separated"]},{"year":2016,"claim":"Defined IL-21's metabolic and epigenetic logic—driving OXPHOS-dependent CD8 stemness, NK ADCC enhancement, and a STAT3/NFAT-dependent long-range enhancer loop controlling its own expression.","evidence":"Ldha deletion and metabolic profiling with adoptive transfer; NK ADCC/ERK/STAT1 assays with xenografts; 3C/4C chromatin conformation with STAT3/NFAT ChIP","pmids":["32123114","27435400","27067007"],"confidence":"High","gaps":["How the distal enhancer is silenced in Tregs only partly defined","Transcription-factor circuitry coupling metabolism to stemness not fully mapped"]},{"year":2018,"claim":"Showed IL-21 transcription is epigenetically gated by c-Maf SUMOylation state, which switches the locus between Daxx/HDAC2 repression and CBP/p300-mediated histone acetylation, driving diabetogenic extrafollicular help.","evidence":"Transgenic NOD mice with SUMO-mutant c-Maf, ChIP at Il21 promoter, CBP/p300 inhibitor","pmids":["30059018"],"confidence":"High","gaps":["Upstream signals controlling c-Maf SUMOylation not defined","Interaction with STAT3/c-Rel inputs at the locus unresolved"]},{"year":2019,"claim":"Established active repression and apoptosis arms of the axis: NR2F6 directly silences Il21 in resting T cells until Tfh differentiation, while IL-21 kills Foxp3+ Tregs via Bcl-2 family suppression to amplify Th2 inflammation.","evidence":"NR2F6 ChIP and Nr2f6-KO mice with IL-21R-blockade rescue; mixed chimeras and competitive transfer with Bcl-2 family apoptosis analysis","pmids":["31509749","30654048"],"confidence":"High","gaps":["Signal that releases NR2F6 from the locus during Tfh differentiation not identified","Bcl-2 family target(s) most responsible for Treg death not pinpointed"]},{"year":2020,"claim":"Demonstrated IL-21 can reprogram differentiated effector CD8 T cells toward central-memory states when chromatin at the CD28 locus is opened, with pSTAT3 binding driving CD28/CD62L re-expression.","evidence":"HDACi plus IL-21 with ChIP/ATAC at CD28, pSTAT3 binding, and memory transcriptional signatures","pmids":["32213626"],"confidence":"Medium","gaps":["Stability of reprogrammed state in vivo not established here","Genome-wide pSTAT3 targets in reprogramming not mapped"]},{"year":2023,"claim":"Refined IL-21's germinal-center mechanism through cell-cycle and signal-strength control—cyclin D3/Foxo1-tuned dark-zone entry and heparan-sulfate-gated IL-21 bioavailability—and extended its pathogenic role to checkpoint-induced thyroiditis and Treg pyroptosis in chronic rhinosinusitis.","evidence":"IL-21R-KO GC analyses with cyclin D3/Foxo1; Ndst1-KO B cells with HS biochemistry; scRNA-seq plus IL-21-KO ICI-thyroiditis model; pyroptosis markers and Akt-mTOR-NLRP3 inhibition in ECRS","pmids":["37466652","36800411","37196065","37164271"],"confidence":"High","gaps":["How Foxo1 is regulated by IL-21 signaling not fully defined","Connection between HS desensitization and downstream STAT output not quantified"]},{"year":null,"claim":"How the multiple transcriptional inputs (c-Rel, c-Maf, NR2F6, STAT3/NFAT enhancer looping) and the STAT1/STAT3 balance are integrated to set IL-21 dose and downstream program in each cell type remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking locus regulation to per-cell output","Quantitative rules for IL-21 signal strength across receiving cell types not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[4,24]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[4,9]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[1,13]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,1,4,9]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,9,20]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[12,19,28]}],"complexes":[],"partners":["IL21R","STAT3","STAT1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9HBE4","full_name":"Interleukin-21","aliases":["Za11"],"length_aa":162,"mass_kda":18.7,"function":"Cytokine with immunoregulatory activity. May promote the transition between innate and adaptive immunity. Induces the production of IgG(1) and IgG(3) in B-cells (By similarity). Implicated in the generation and maintenance of T follicular helper (Tfh) cells and the formation of germinal-centers. Together with IL6, control the early generation of Tfh cells and are critical for an effective antibody response to acute viral infection (By similarity). May play a role in proliferation and maturation of natural killer (NK) cells in synergy with IL15. May regulate proliferation of mature B- and T-cells in response to activating stimuli. In synergy with IL15 and IL18 stimulates interferon gamma production in T-cells and NK cells (PubMed:11081504, PubMed:15178704). During T-cell mediated immune response may inhibit dendritic cells (DC) activation and maturation (By similarity)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q9HBE4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/IL21","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/IL21","total_profiled":1310},"omim":[{"mim_id":"621524","title":"WD REPEAT- AND SOCS BOX-CONTAINING PROTEIN 2; WSB2","url":"https://www.omim.org/entry/621524"},{"mim_id":"619652","title":"IMMUNODEFICIENCY 92; IMD92","url":"https://www.omim.org/entry/619652"},{"mim_id":"618998","title":"IMMUNE DYSREGULATION AND SYSTEMIC HYPERINFLAMMATION SYNDROME; IMDYSHI","url":"https://www.omim.org/entry/618998"},{"mim_id":"615767","title":"IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11","url":"https://www.omim.org/entry/615767"},{"mim_id":"615231","title":"RING FINGER AND CCCH-TYPE ZINC FINGER DOMAINS-CONTAINING PROTEIN 2; RC3H2","url":"https://www.omim.org/entry/615231"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":5.5}],"url":"https://www.proteinatlas.org/search/IL21"},"hgnc":{"alias_symbol":["Za11","IL-21"],"prev_symbol":[]},"alphafold":{"accession":"Q9HBE4","domains":[{"cath_id":"1.20.1250.70","chopping":"30-110_120-154","consensus_level":"high","plddt":92.5551,"start":30,"end":154}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HBE4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HBE4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HBE4-F1-predicted_aligned_error_v6.png","plddt_mean":83.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=IL21","jax_strain_url":"https://www.jax.org/strain/search?query=IL21"},"sequence":{"accession":"Q9HBE4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9HBE4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9HBE4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HBE4"}},"corpus_meta":[{"pmid":"17581589","id":"PMC_17581589","title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T cells.","date":"2007","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/17581589","citation_count":1206,"is_preprint":false},{"pmid":"20142430","id":"PMC_20142430","title":"IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism.","date":"2010","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20142430","citation_count":641,"is_preprint":false},{"pmid":"22279576","id":"PMC_22279576","title":"Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22279576","citation_count":535,"is_preprint":false},{"pmid":"29717110","id":"PMC_29717110","title":"IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29717110","citation_count":465,"is_preprint":false},{"pmid":"20048285","id":"PMC_20048285","title":"B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans.","date":"2010","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20048285","citation_count":338,"is_preprint":false},{"pmid":"17312126","id":"PMC_17312126","title":"IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17312126","citation_count":314,"is_preprint":false},{"pmid":"16778988","id":"PMC_16778988","title":"The IL-21 receptor augments Th2 effector function and alternative macrophage activation.","date":"2006","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/16778988","citation_count":284,"is_preprint":false},{"pmid":"31536480","id":"PMC_31536480","title":"PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21.","date":"2019","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/31536480","citation_count":249,"is_preprint":false},{"pmid":"14764669","id":"PMC_14764669","title":"IL-21 induces the functional maturation of murine NK cells.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/14764669","citation_count":234,"is_preprint":false},{"pmid":"31953246","id":"PMC_31953246","title":"Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma.","date":"2020","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/31953246","citation_count":222,"is_preprint":false},{"pmid":"32123114","id":"PMC_32123114","title":"Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8+ T cell stemness and antitumor immunity.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32123114","citation_count":191,"is_preprint":false},{"pmid":"18613830","id":"PMC_18613830","title":"The role of IL-21 in regulating B-cell function in health and disease.","date":"2008","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/18613830","citation_count":188,"is_preprint":false},{"pmid":"12429707","id":"PMC_12429707","title":"Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses.","date":"2002","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/12429707","citation_count":188,"is_preprint":false},{"pmid":"24600453","id":"PMC_24600453","title":"Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage.","date":"2014","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24600453","citation_count":173,"is_preprint":false},{"pmid":"18779574","id":"PMC_18779574","title":"IL-21 signaling is critical for the development of type I diabetes in the NOD mouse.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18779574","citation_count":171,"is_preprint":false},{"pmid":"23440042","id":"PMC_23440042","title":"Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome.","date":"2013","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23440042","citation_count":163,"is_preprint":false},{"pmid":"15546387","id":"PMC_15546387","title":"Biology of IL-21 and the IL-21 receptor.","date":"2004","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/15546387","citation_count":159,"is_preprint":false},{"pmid":"30773373","id":"PMC_30773373","title":"Clinical significance and immunobiology of IL-21 in autoimmunity.","date":"2019","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/30773373","citation_count":156,"is_preprint":false},{"pmid":"23176102","id":"PMC_23176102","title":"A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis.","date":"2012","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/23176102","citation_count":146,"is_preprint":false},{"pmid":"26966515","id":"PMC_26966515","title":"IL-21 Signaling in Immunity.","date":"2016","source":"F1000Research","url":"https://pubmed.ncbi.nlm.nih.gov/26966515","citation_count":145,"is_preprint":false},{"pmid":"19933709","id":"PMC_19933709","title":"IL-21 and T follicular helper cells.","date":"2009","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19933709","citation_count":145,"is_preprint":false},{"pmid":"27389961","id":"PMC_27389961","title":"IL-21 and T Cell Differentiation: Consider the Context.","date":"2016","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27389961","citation_count":133,"is_preprint":false},{"pmid":"19201828","id":"PMC_19201828","title":"IL-21: an executor of B cell fate.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19201828","citation_count":126,"is_preprint":false},{"pmid":"24014238","id":"PMC_24014238","title":"IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24014238","citation_count":123,"is_preprint":false},{"pmid":"21281812","id":"PMC_21281812","title":"IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain.","date":"2011","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21281812","citation_count":117,"is_preprint":false},{"pmid":"26170288","id":"PMC_26170288","title":"Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26170288","citation_count":110,"is_preprint":false},{"pmid":"18209077","id":"PMC_18209077","title":"Autocrine regulation of IL-21 production in human T lymphocytes.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18209077","citation_count":99,"is_preprint":false},{"pmid":"16424177","id":"PMC_16424177","title":"IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16424177","citation_count":96,"is_preprint":false},{"pmid":"20079789","id":"PMC_20079789","title":"IL-21 regulates Th17 cells in rheumatoid arthritis.","date":"2010","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20079789","citation_count":95,"is_preprint":false},{"pmid":"25586558","id":"PMC_25586558","title":"Interleukin (IL)-21 promotes intestinal IgA response to microbiota.","date":"2015","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25586558","citation_count":93,"is_preprint":false},{"pmid":"19404967","id":"PMC_19404967","title":"Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis.","date":"2009","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/19404967","citation_count":86,"is_preprint":false},{"pmid":"19322899","id":"PMC_19322899","title":"Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.","date":"2009","source":"Inflammatory bowel diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19322899","citation_count":81,"is_preprint":false},{"pmid":"31440249","id":"PMC_31440249","title":"IL-21 Induces an Imbalance of Th17/Treg Cells in Moderate-to-Severe Plaque Psoriasis Patients.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31440249","citation_count":80,"is_preprint":false},{"pmid":"25961061","id":"PMC_25961061","title":"IL-21: a pleiotropic cytokine with potential applications in oncology.","date":"2015","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/25961061","citation_count":79,"is_preprint":false},{"pmid":"34224936","id":"PMC_34224936","title":"New developments implicating IL-21 in autoimmune disease.","date":"2021","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/34224936","citation_count":70,"is_preprint":false},{"pmid":"20112382","id":"PMC_20112382","title":"Confirmation of an association between rs6822844 at the Il2-Il21 region and multiple autoimmune diseases: evidence of a general susceptibility locus.","date":"2010","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/20112382","citation_count":68,"is_preprint":false},{"pmid":"23437182","id":"PMC_23437182","title":"Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23437182","citation_count":67,"is_preprint":false},{"pmid":"23696736","id":"PMC_23696736","title":"IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection.","date":"2013","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/23696736","citation_count":65,"is_preprint":false},{"pmid":"26466984","id":"PMC_26466984","title":"Biological effects of IL-21 on different immune cells and its role in autoimmune diseases.","date":"2015","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/26466984","citation_count":64,"is_preprint":false},{"pmid":"20639489","id":"PMC_20639489","title":"Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.","date":"2010","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20639489","citation_count":62,"is_preprint":false},{"pmid":"25321844","id":"PMC_25321844","title":"Human IL-21 and IL-21R deficiencies: two novel entities of primary immunodeficiency.","date":"2014","source":"Current opinion in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/25321844","citation_count":60,"is_preprint":false},{"pmid":"25801685","id":"PMC_25801685","title":"Advances in IL-21 biology - enhancing our understanding of human disease.","date":"2015","source":"Current opinion in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25801685","citation_count":60,"is_preprint":false},{"pmid":"27435400","id":"PMC_27435400","title":"IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells.","date":"2016","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/27435400","citation_count":59,"is_preprint":false},{"pmid":"28918288","id":"PMC_28918288","title":"Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer.","date":"2017","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28918288","citation_count":56,"is_preprint":false},{"pmid":"15178704","id":"PMC_15178704","title":"IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells.","date":"2004","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/15178704","citation_count":54,"is_preprint":false},{"pmid":"19845910","id":"PMC_19845910","title":"IL-21: roles in immunopathology and cancer therapy.","date":"2009","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/19845910","citation_count":52,"is_preprint":false},{"pmid":"30111631","id":"PMC_30111631","title":"IL-21 Selectively Protects CD62L+ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30111631","citation_count":51,"is_preprint":false},{"pmid":"26491200","id":"PMC_26491200","title":"IL-21 and IL-4 Collaborate To Shape T-Dependent Antibody Responses.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/26491200","citation_count":50,"is_preprint":false},{"pmid":"17624663","id":"PMC_17624663","title":"High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma.","date":"2007","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/17624663","citation_count":48,"is_preprint":false},{"pmid":"36800411","id":"PMC_36800411","title":"Heparan sulfate regulates IL-21 bioavailability and signal strength that control germinal center B cell selection and differentiation.","date":"2023","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36800411","citation_count":47,"is_preprint":false},{"pmid":"20072139","id":"PMC_20072139","title":"Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis.","date":"2010","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/20072139","citation_count":47,"is_preprint":false},{"pmid":"28875978","id":"PMC_28875978","title":"IL4 and IL21 cooperate to induce the high Bcl6 protein level required for germinal center formation.","date":"2017","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28875978","citation_count":46,"is_preprint":false},{"pmid":"31921177","id":"PMC_31921177","title":"T Follicular Helper Cell Subsets and the Associated Cytokine IL-21 in the Pathogenesis and Therapy of Asthma.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31921177","citation_count":46,"is_preprint":false},{"pmid":"19608866","id":"PMC_19608866","title":"IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma.","date":"2009","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19608866","citation_count":45,"is_preprint":false},{"pmid":"18670213","id":"PMC_18670213","title":"IL-21 augments natural killer effector functions in chronically HIV-infected individuals.","date":"2008","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18670213","citation_count":44,"is_preprint":false},{"pmid":"35801309","id":"PMC_35801309","title":"IL-21 has a critical role in establishing germinal centers by amplifying early B cell proliferation.","date":"2022","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/35801309","citation_count":43,"is_preprint":false},{"pmid":"21425124","id":"PMC_21425124","title":"Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21.","date":"2011","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/21425124","citation_count":42,"is_preprint":false},{"pmid":"33924897","id":"PMC_33924897","title":"The Roles of IL-17, IL-21, and IL-23 in the Helicobacter pylori Infection and Gastrointestinal Inflammation: A Review.","date":"2021","source":"Toxins","url":"https://pubmed.ncbi.nlm.nih.gov/33924897","citation_count":42,"is_preprint":false},{"pmid":"37164271","id":"PMC_37164271","title":"IL-21 induces pyroptosis of Treg cells via Akt-mTOR-NLRP3-caspase 1 axis in eosinophilic chronic rhinosinusitis.","date":"2023","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37164271","citation_count":41,"is_preprint":false},{"pmid":"23236436","id":"PMC_23236436","title":"Gene-gene and gene-sex epistatic interactions of MiR146a, IRF5, IKZF1, ETS1 and IL21 in systemic lupus erythematosus.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23236436","citation_count":39,"is_preprint":false},{"pmid":"27819295","id":"PMC_27819295","title":"IL-21 signaling is essential for optimal host resistance against Mycobacterium tuberculosis infection.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27819295","citation_count":39,"is_preprint":false},{"pmid":"30654048","id":"PMC_30654048","title":"IL-21 promotes allergic airway inflammation by driving apoptosis of FoxP3+ regulatory T cells.","date":"2019","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30654048","citation_count":38,"is_preprint":false},{"pmid":"37196065","id":"PMC_37196065","title":"Clonally expanded, thyrotoxic effector CD8+ T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis.","date":"2023","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37196065","citation_count":37,"is_preprint":false},{"pmid":"14610289","id":"PMC_14610289","title":"IL-21 and IL-21 receptor: a new cytokine pathway modulates innate and adaptive immunity.","date":"2003","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/14610289","citation_count":37,"is_preprint":false},{"pmid":"25724205","id":"PMC_25724205","title":"Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation.","date":"2015","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25724205","citation_count":36,"is_preprint":false},{"pmid":"33157566","id":"PMC_33157566","title":"IFN-γ+ IL-17+ Th17 cells regulate fibrosis through secreting IL-21 in systemic scleroderma.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33157566","citation_count":36,"is_preprint":false},{"pmid":"18418394","id":"PMC_18418394","title":"Association study of IL2/IL21 and FcgRIIa: significant association with the IL2/IL21 region in Scandinavian coeliac disease families.","date":"2008","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18418394","citation_count":34,"is_preprint":false},{"pmid":"37910044","id":"PMC_37910044","title":"Cooperative Armoring of CAR and TCR T Cells by T Cell-Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy.","date":"2024","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/37910044","citation_count":33,"is_preprint":false},{"pmid":"22566888","id":"PMC_22566888","title":"The Interplay of IL-21 and BAFF in the Formation and Maintenance of Human B Cell Memory.","date":"2012","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22566888","citation_count":33,"is_preprint":false},{"pmid":"25584898","id":"PMC_25584898","title":"A pathogenetic role for IL-21 in primary Sjögren syndrome.","date":"2015","source":"Nature reviews. Rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/25584898","citation_count":32,"is_preprint":false},{"pmid":"26507681","id":"PMC_26507681","title":"IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis.","date":"2015","source":"Journal of immunotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/26507681","citation_count":31,"is_preprint":false},{"pmid":"25495679","id":"PMC_25495679","title":"Increased IL-21 expression in chronic rhinosinusitis with nasalpolyps.","date":"2015","source":"Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25495679","citation_count":31,"is_preprint":false},{"pmid":"35624463","id":"PMC_35624463","title":"CXCL13 expressed on inflamed cerebral blood vessels recruit IL-21 producing TFH cells to damage neurons following stroke.","date":"2022","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/35624463","citation_count":31,"is_preprint":false},{"pmid":"31622625","id":"PMC_31622625","title":"Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21.","date":"2019","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/31622625","citation_count":30,"is_preprint":false},{"pmid":"17447063","id":"PMC_17447063","title":"Role of IL-21 in immune-regulation and tumor immunotherapy.","date":"2007","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/17447063","citation_count":29,"is_preprint":false},{"pmid":"33929673","id":"PMC_33929673","title":"Genomic Spectrum and Phenotypic Heterogeneity of Human IL-21 Receptor Deficiency.","date":"2021","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33929673","citation_count":29,"is_preprint":false},{"pmid":"23561933","id":"PMC_23561933","title":"Comparison of vascular leak syndrome in mice treated with IL21 or IL2.","date":"2013","source":"Comparative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23561933","citation_count":29,"is_preprint":false},{"pmid":"31867283","id":"PMC_31867283","title":"Interleukin (IL)-21 in Inflammation and Immunity During Parasitic Diseases.","date":"2019","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31867283","citation_count":28,"is_preprint":false},{"pmid":"32213626","id":"PMC_32213626","title":"Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8+ T Cells to Memory T Cells.","date":"2020","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/32213626","citation_count":28,"is_preprint":false},{"pmid":"27602031","id":"PMC_27602031","title":"The Biological Effects of IL-21 Signaling on B-Cell-Mediated Responses in Organ Transplantation.","date":"2016","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27602031","citation_count":28,"is_preprint":false},{"pmid":"31509749","id":"PMC_31509749","title":"Orphan Nuclear Receptor NR2F6 Suppresses T Follicular Helper Cell Accumulation through Regulation of IL-21.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31509749","citation_count":28,"is_preprint":false},{"pmid":"22013017","id":"PMC_22013017","title":"IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response.","date":"2011","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/22013017","citation_count":28,"is_preprint":false},{"pmid":"35802683","id":"PMC_35802683","title":"Anti-GD2 Antibodies Conjugated to IL15 and IL21 Mediate Potent Antitumor Cytotoxicity against Neuroblastoma.","date":"2022","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/35802683","citation_count":27,"is_preprint":false},{"pmid":"18353312","id":"PMC_18353312","title":"IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis.","date":"2007","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18353312","citation_count":27,"is_preprint":false},{"pmid":"34135061","id":"PMC_34135061","title":"CD40L-Stimulated B Lymphocytes Are Polarized toward APC Functions after Exposure to IL-4 and IL-21.","date":"2021","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/34135061","citation_count":27,"is_preprint":false},{"pmid":"30087442","id":"PMC_30087442","title":"Defective IgA response to atypical intestinal commensals in IL-21 receptor deficiency reshapes immune cell homeostasis and mucosal immunity.","date":"2018","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30087442","citation_count":27,"is_preprint":false},{"pmid":"23354321","id":"PMC_23354321","title":"IL21 and IL21R polymorphisms and their interactive effects on serum IL-21 and IgE levels in patients with chronic hepatitis B virus infection.","date":"2013","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23354321","citation_count":26,"is_preprint":false},{"pmid":"18656702","id":"PMC_18656702","title":"Effective collaboration between IL-4 and IL-21 on B cell activation.","date":"2008","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/18656702","citation_count":26,"is_preprint":false},{"pmid":"23216614","id":"PMC_23216614","title":"Role of IL-21 and IL-21 receptor on B cells in HIV infection.","date":"2012","source":"Critical reviews in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23216614","citation_count":25,"is_preprint":false},{"pmid":"30348636","id":"PMC_30348636","title":"Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma.","date":"2018","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/30348636","citation_count":24,"is_preprint":false},{"pmid":"25162763","id":"PMC_25162763","title":"IL-21 as a therapeutic target in inflammatory disorders.","date":"2014","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/25162763","citation_count":24,"is_preprint":false},{"pmid":"30059018","id":"PMC_30059018","title":"SUMO-defective c-Maf preferentially transactivates Il21 to exacerbate autoimmune diabetes.","date":"2018","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/30059018","citation_count":24,"is_preprint":false},{"pmid":"25603233","id":"PMC_25603233","title":"Association of IL-21 cytokine with severity of primary Sjögren syndrome dry eye.","date":"2015","source":"Cornea","url":"https://pubmed.ncbi.nlm.nih.gov/25603233","citation_count":24,"is_preprint":false},{"pmid":"27157859","id":"PMC_27157859","title":"CCL21/IL21-armed oncolytic adenovirus enhances antitumor activity against TERT-positive tumor cells.","date":"2016","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/27157859","citation_count":23,"is_preprint":false},{"pmid":"27067007","id":"PMC_27067007","title":"Dynamic Long-Range Chromatin Interaction Controls Expression of IL-21 in CD4+ T Cells.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27067007","citation_count":23,"is_preprint":false},{"pmid":"22250707","id":"PMC_22250707","title":"Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target.","date":"2012","source":"Current pharmaceutical biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/22250707","citation_count":22,"is_preprint":false},{"pmid":"29849593","id":"PMC_29849593","title":"Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease.","date":"2018","source":"Gastroenterology research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/29849593","citation_count":22,"is_preprint":false},{"pmid":"37466652","id":"PMC_37466652","title":"IL-21 shapes germinal center polarization via light zone B cell selection and cyclin D3 upregulation.","date":"2023","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37466652","citation_count":22,"is_preprint":false},{"pmid":"32060889","id":"PMC_32060889","title":"IL-21 Signaling in the Tumor Microenvironment.","date":"2020","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/32060889","citation_count":21,"is_preprint":false},{"pmid":"36447054","id":"PMC_36447054","title":"LncRNA IL21-AS1 interacts with hnRNPU protein to promote IL21 overexpression and aberrant differentiation of Tfh cells in systemic lupus erythematosus.","date":"2022","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36447054","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49573,"output_tokens":8343,"usd":0.136932,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18283,"output_tokens":5693,"usd":0.11687,"stage2_stop_reason":"end_turn"},"total_usd":0.253802,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"IL-21 is produced by Th17 cells and acts as an autocrine cytokine sufficient and necessary for Th17 differentiation. IL-6 induces IL-21 in activated T cells via STAT3 (but not ROR-γ). IL-21 in turn potently induces Th17 differentiation and suppresses Foxp3 expression, requiring both STAT3 and ROR-γ (Rorc). IL-21 deficiency impairs Th17 generation and protects against experimental autoimmune encephalomyelitis.\",\n      \"method\": \"Genetic knockout (IL-21-deficient mice), cytokine stimulation assays, STAT3/ROR-γ pathway analysis, EAE model\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype, multiple orthogonal methods including genetic rescue and in vivo disease model\",\n      \"pmids\": [\"17581589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"IL-21 signaling acts directly on B cells (B cell-intrinsic) to maintain Bcl-6 expression in germinal center B cells, regulate GC persistence and proliferation, promote plasma cell and memory B cell formation, and support affinity maturation. CD3-expressing cells are the source of IL-21 acting on B cells in vivo.\",\n      \"method\": \"Bone marrow chimeras with IL-21R-deficient and wild-type cells, protein antigen immunization, flow cytometry, gene expression analysis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — bone marrow chimera epistasis definitively placing IL-21 action on B cells, multiple orthogonal readouts including affinity maturation and Bcl-6 expression\",\n      \"pmids\": [\"20142430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"IL-21-induced B cell differentiation into plasma cells in humans requires B cell-intrinsic STAT3 signaling. STAT3 loss-of-function mutations abolish IL-21-driven naive B cell differentiation into plasma cells and reduce antigen-specific memory B cells. STAT1 deficiency has no effect on IL-21-induced immunoglobulin secretion in vitro.\",\n      \"method\": \"Studies of patients with inactivating STAT1 or STAT3 mutations, in vitro IL-21 stimulation assays, immunoglobulin secretion measurement\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human loss-of-function mutations with defined cellular phenotype, two orthogonal patient cohorts, replicated by multiple methods\",\n      \"pmids\": [\"20048285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IL-21 induces its own expression in human T cells via an autocrine loop: IL-21 activates STAT3, which is recruited to the IL-21 gene promoter to enhance IL-21 transcription. Pharmacological inhibition or siRNA knockdown of STAT3 prevents IL-21 auto-induction.\",\n      \"method\": \"STAT3 inhibition, siRNA knockdown, promoter ChIP assay, cytokine stimulation of human peripheral blood and lamina propria T cells\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP demonstrating STAT3 binding to IL-21 promoter plus siRNA knockdown with functional readout, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"18209077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Loss-of-function mutations in IL21R cause primary immunodeficiency. The IL-21R Arg201Leu mutation causes aberrant trafficking of IL-21R to the plasma membrane, abrogates IL-21 ligand binding, and leads to defective phosphorylation of STAT1, STAT3, and STAT5, resulting in impaired B cell proliferation, immunoglobulin class-switching, T cell cytokine production, and NK cell cytotoxicity.\",\n      \"method\": \"Exome sequencing, candidate gene sequencing, receptor trafficking assays, IL-21 ligand binding assays, STAT phosphorylation assays, functional lymphocyte assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human loss-of-function mutations with mechanistic characterization of receptor trafficking and signaling defects using multiple methods\",\n      \"pmids\": [\"23440042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"IL-21 down-regulates NKG2D surface expression on human NK and CD8+ T cells by dramatically reducing DAP10 promoter activity, thereby attenuating NKG2D-mediated NK cell cytotoxicity and degranulation. Conversely, IL-21 induces expression of NK activation receptors NKp30 and 2B4, and costimulatory receptor CD28 on CD8+ T cells.\",\n      \"method\": \"Cell culture with human primary NK and CD8+ T cells, NKG2D redirected lysis assays, degranulation assays, DAP10 luciferase reporter construct, transcript analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — luciferase reporter (Tier 1) plus functional cytotoxicity assays and transcript analysis, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"16424177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The IL-21 receptor augments Th2 effector function and alternative macrophage activation in vivo. IL-21 significantly augments IL-4Rα and IL-13Rα1 expression in macrophages, resulting in increased FIZZ1 mRNA and arginase-1 activity following IL-4 and IL-13 stimulation. IL-21R deficiency reduces granulomatous inflammation, liver fibrosis, and Th2 cytokine responses to helminth infection.\",\n      \"method\": \"IL-21R-knockout mice infected with Schistosoma mansoni and Nippostrongylus brasiliensis, soluble IL-21R-Fc blockade, in vitro macrophage stimulation assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined cellular phenotype in two parasite infection models, plus in vitro mechanistic receptor upregulation data\",\n      \"pmids\": [\"16778988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IL-21 signaling through IL-21R is critical for the development of type 1 diabetes in the NOD mouse. IL-21R-knockout NOD mice are devoid of pancreatic lymphocytic infiltration and are protected from diabetes. This correlates with reduced Th17 cells and significantly higher expression of Reg family genes whose products protect against diabetes.\",\n      \"method\": \"IL-21R KO backcrossed to NOD mice, glucose monitoring, histological analysis, T cell and Treg functional assays, Reg gene mRNA quantification\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined in vivo phenotype in autoimmune disease model, multiple mechanistic readouts\",\n      \"pmids\": [\"18779574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The NF-κB transcription factor c-Rel is required for IL-21 gene expression in T lymphocytes. c-Rel binds a specific site in the proximal il21 promoter, confirmed in vitro and in vivo by ChIP. IL-21 mRNA and protein are reduced in CD4+ T cells from rel−/− mice. Administration of IL-21 protein rescues Tfh cell development but not germinal center B cell development in rel−/− mice.\",\n      \"method\": \"c-Rel KO mice, ChIP assay for c-Rel promoter binding, IL-21 rescue experiments, flow cytometry of T and B cell populations\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP demonstrating direct c-Rel binding to il21 promoter, KO phenotype with in vivo IL-21 rescue, single lab with multiple methods\",\n      \"pmids\": [\"20639489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"STAT1 and STAT3 have opposing roles in IL-21 signaling in CD4+ T cells. IL-21 activates both STAT1 and STAT3; STAT1 phosphorylation is augmented in Stat3-deficient CD4+ T cells. RNA-Seq in Stat1- and Stat3-deficient mice shows both are critical for IL-21-mediated gene regulation. STAT1 and STAT3 differentially regulate Tbx21 and Ifng expression, with opposing in vivo roles during chronic LCMV infection.\",\n      \"method\": \"Stat1- and Stat3-deficient mice, RNA-Seq, phosphorylation assays, chronic LCMV infection model, patient samples (STAT3-deficient/STAT1 gain-of-function patients)\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — RNA-Seq with KO mouse models, validated in vivo and in human primary cells with distinct genetic defects, multiple orthogonal methods\",\n      \"pmids\": [\"26170288\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IL-21 directly inhibits Treg cell expansion in a cell-intrinsic manner during chronic LCMV infection. In IL-21R−/− mice, virus-driven Treg cell expansion is greatly enhanced. IL-21 restricts Treg proliferation, and augmented Treg expansion (via IL-2/anti-IL-2 immune complexes) impairs antiviral T cell responses and promotes viral persistence.\",\n      \"method\": \"IL-21R KO mice, LCMV infection model, Treg depletion, IL-2/anti-IL-2 complex administration, flow cytometry of CD8+ T cell function\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined in vivo phenotype, multiple epistatic experiments, cell-intrinsic mechanism established\",\n      \"pmids\": [\"23696736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"IL-21 promotes CD8+ T cell stemness and stem cell memory T cell (TSCM) formation through maintaining metabolic quiescence dependent on oxidative phosphorylation, in contrast to IL-2 which drives aerobic glycolysis via LDH induction. LDH inhibition combined with IL-21 synergistically increases TSCM formation and antitumor responses.\",\n      \"method\": \"Metabolic profiling (OXPHOS vs glycolysis), LDH inhibition, Ldha gene deletion, adoptive transfer tumor models, transcriptomic analysis\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic deletion of Ldha, metabolic profiling, adoptive transfer functional validation, multiple orthogonal methods in single study\",\n      \"pmids\": [\"32123114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"IL-21 directly promotes apoptosis of Foxp3+ regulatory T cells by interfering with Bcl-2 family gene expression, thereby indirectly sustaining generation of inflammatory TH cells and TH2-driven asthmatic responses. This cell-intrinsic effect was demonstrated using mixed bone marrow chimeras and competitive adoptive transfer experiments.\",\n      \"method\": \"IL-21R-deficient mice, mixed bone marrow chimeras, adoptive transfer of Treg cells, Treg depletion experiments, in vitro apoptosis assays with Bcl-2 family gene analysis\",\n      \"journal\": \"The Journal of allergy and clinical immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mixed chimeras and competitive transfers establishing cell-intrinsic mechanism, Bcl-2 family molecular mechanism, multiple orthogonal models\",\n      \"pmids\": [\"30654048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CD40L combined with IL-21 is sufficient to induce robust proliferation of CLL cells, defining an IL-21-induced gene signature containing JAK/STAT and apoptosis pathway components. IL-21 production by CD4+CXCR5+ follicular helper T cells was detected in lymph nodes, where IL-21 RNA and protein were also found.\",\n      \"method\": \"Co-culture of CLL cells with autologous T cells or recombinant CD40L+IL-21, gene expression profiling, in situ detection of IL-21 in lymph node samples, ELISA\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined minimal signal (CD40L+IL-21) sufficient for CLL proliferation, gene signature validated in patient LN samples, single lab\",\n      \"pmids\": [\"24014238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"IFN-α/β enhances IL-21 mRNA expression in activated human T cells and an IFN-γ activation site (GAS) element in the IL-21 promoter binds STAT1, STAT2, STAT3, and STAT4 in IFN-α/β-stimulated NK or T cell extracts. Conversely, IFN-α/β down-regulates IL-21R expression in NK and T cells, resulting in reduced STAT3 phosphorylation and DNA binding after IL-21 stimulation.\",\n      \"method\": \"Promoter analysis with gel shift (EMSA), mRNA expression analysis, STAT3 phosphorylation assays in human NK and T cells\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA demonstrating STAT factor binding to IL-21 promoter GAS element, functional signaling readout, single lab\",\n      \"pmids\": [\"15178704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"IL-21 enhances NK cell signal transduction via activation of ERK and STAT1 when responding to cetuximab-coated pancreatic tumor cells, and increases NK cell-mediated ADCC, IFN-γ secretion, and T cell chemotaxis. In vivo, mIL-21 combined with cetuximab significantly inhibits tumor growth in pancreatic cancer xenograft models.\",\n      \"method\": \"NK cell activation assays (ADCC, IFN-γ ELISA), ERK/STAT1 phosphorylation analysis, subcutaneous and intraperitoneal xenograft models\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined signaling mechanism (ERK/STAT1) with functional validation in vitro and in vivo, single lab\",\n      \"pmids\": [\"27435400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Bruton's tyrosine kinase (Btk) amplifies IL-21 signaling in human B cells by mediating nuclear (but not cytoplasmic) STAT1 phosphorylation downstream of IL-21 combined with BCR and CD40 signals. Btk inhibition suppresses IL-21-induced B cell differentiation and IgG production.\",\n      \"method\": \"Btk inhibitor treatment, phosphorylation assays distinguishing nuclear vs cytoplasmic STAT1, BJAB cell line signaling assays, flow cytometry, ELISA\",\n      \"journal\": \"Rheumatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined nuclear STAT1 phosphorylation as Btk-dependent downstream of IL-21, pharmacological and subcellular fractionation evidence, single lab\",\n      \"pmids\": [\"25724205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"IL-4 and IL-21 cooperate to maintain high Bcl-6 protein levels required for germinal center formation. IL-21 prevents BCR-mediated proteasomal degradation of Bcl-6. Combined B cell-intrinsic loss of IL-4 and IL-21 signaling almost completely eliminates the GC response in vivo.\",\n      \"method\": \"Bcl-6 protein stability assays in stimulated B cells, conditional KO mice for IL-4R and IL-21R signaling, flow cytometry of GC populations\",\n      \"journal\": \"Immunology and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — protein stability mechanistic assay plus in vivo KO epistasis, single lab with orthogonal methods\",\n      \"pmids\": [\"28875978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NR4A2 (nuclear receptor) controls full Th17 differentiation via autocrine IL-21 signaling. When NR4A2 expression is blocked by siRNA, Th17 cells express RORγt but fail to produce IL-17 and IL-21, and this differentiation defect is rescued by exogenous IL-21. In vivo NR4A2 siRNA treatment reduces Th17 effector responses and protects against EAE.\",\n      \"method\": \"siRNA knockdown of NR4A2 in vitro, exogenous IL-21 rescue experiment, in vivo siRNA treatment, EAE model, flow cytometry\",\n      \"journal\": \"PLoS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA KD with IL-21 rescue establishing epistatic relationship, in vivo confirmation, single lab\",\n      \"pmids\": [\"23437182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"IL-21 induces apoptosis of follicular lymphoma cells (carrying t(14;18)) via caspase-8 and caspase-3 activation, reduction of mitochondrial membrane potential, decreased Bcl-2 expression, and increased Bax expression. In contrast, IL-21 stimulates growth of Burkitt lymphoma and T cell leukemia lines.\",\n      \"method\": \"In vitro IL-21 treatment of lymphoma cell lines, caspase activity assays, mitochondrial membrane potential measurement, Bcl-2/Bax protein expression\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple mechanistic apoptosis assays in cell lines, single lab, consistent results across methods\",\n      \"pmids\": [\"17624663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"IL-21 contributes to JAK3/STAT3 activation and cell growth in ALK+ anaplastic large cell lymphoma. Recombinant IL-21 enhances JAK3/STAT3 activation and increases cell growth; siRNA knockdown of IL-21R decreases STAT3 activation and cell growth. IL-21R expression is independent of NPM-ALK.\",\n      \"method\": \"Recombinant IL-21 treatment, IL-21R siRNA knockdown, JAK3/STAT3 phosphorylation assays, cell growth assays, NPM-ALK overexpression/knockdown\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with defined signaling readout, reciprocal gain/loss approach, single lab\",\n      \"pmids\": [\"19608866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"IL-21 enhances IL-21 gene expression through a long-range chromatin interaction mechanism. A conserved noncoding sequence 49 kb upstream of IL-21 acts as an enhancer in a STAT3- and NFAT-dependent manner. IL-6/STAT3 signaling induces dynamic chromatin looping between the IL-21 promoter and distal enhancer. This interaction is absent in regulatory T cells where IL-21 expression is repressed.\",\n      \"method\": \"Chromosome conformation capture (3C/4C), ChIP for STAT3 and NFAT, CTCF binding assays, enhancer reporter assays, naive vs regulatory T cell comparisons\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — chromatin conformation capture plus ChIP demonstrating STAT3 binding and enhancer activity, multiple orthogonal epigenomic methods in single study\",\n      \"pmids\": [\"27067007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SUMO-defective c-Maf preferentially transactivates Il21 by selectively inhibiting recruitment of the Daxx/HDAC2 repressor complex to the Il21 promoter and enhancing histone acetylation via CBP and p300. This epigenetic mechanism promotes extrafollicular helper T cell development and IL-21-mediated diabetogenesis in NOD mice.\",\n      \"method\": \"Transgenic NOD mice with WT or SUMOylation-mutant c-Maf, ChIP for Daxx/HDAC2 and histone acetylation at Il21 promoter, CBP/p300 inhibitor (CBP30) treatment, diabetes incidence monitoring\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP demonstrating chromatin mechanism at Il21 promoter, transgenic mouse epistasis, pharmacological validation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"30059018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The orphan nuclear receptor NR2F6 directly binds the IL-21 promoter and a conserved noncoding sequence near the Il21 gene in resting CD4+ T cells to repress IL-21 transcription. During Tfh cell differentiation, this NR2F6 DNA interaction is abolished, allowing Il21 expression. Enhanced Tfh cell accumulation in Nr2f6-deficient mice is reversed by blocking IL-21R signaling.\",\n      \"method\": \"ChIP demonstrating NR2F6 binding to IL-21 promoter and CNS, Nr2f6-deficient mice, IL-21R blockade rescue experiment, flow cytometry\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP demonstrating direct transcription factor binding to IL-21 regulatory elements, KO mouse with genetic rescue by IL-21R blockade, single lab with multiple methods\",\n      \"pmids\": [\"31509749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Heparan sulfate (HS) regulates IL-21 bioavailability and signal strength in germinal center B cells. N-deacetylase and N-sulfotransferase 1 (Ndst1)-mediated N-sulfation of HS in B cells promotes IL-21 binding and signaling. GC B cells have reduced HS sulfation compared to non-GC cells, attenuating IL-21 signaling. Ndst1 is down-regulated in GC B cells and up-regulated in ASC precursors, enabling selective desensitization to IL-21 in the GC and strong signaling in ASC differentiation.\",\n      \"method\": \"IL-21 binding assays on GC vs non-GC B cells, Ndst1-deficient B cell analysis, HS sulfation biochemical assays, in vivo GC and ASC differentiation analysis\",\n      \"journal\": \"Science immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — biochemical characterization of HS modification controlling IL-21 binding, genetic KO of Ndst1, in vivo functional validation, single study with multiple orthogonal methods\",\n      \"pmids\": [\"36800411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"IL-21 acts as a key regulator of the initial B cell response by accelerating cell cycle progression and rate of cycle entry, increasing B cell contribution to the germinal center. This effect occurs across a range of BCR affinities and correlates with elevated AKT and S6 phosphorylation. The increased proliferation mechanistically explains IL-21-mediated promotion of plasma cell differentiation.\",\n      \"method\": \"B cell transfer and immunization models with IL-21R-deficient and WT cells, cell cycle analysis, AKT and S6 phosphorylation assays, flow cytometry\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO epistasis with defined cell cycle and signaling mechanism, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"35801309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"IL-21 shapes germinal center polarization by promoting selection of light zone GC B cells for dark zone entry and triggering cyclin D3 upregulation in GC B cells to tune inertial cell cycling. IL-21R deficiency results in smaller GC skewed toward light zone phenotype. Foxo1 regulation links IL-21 signaling to dark zone GC B cell formation.\",\n      \"method\": \"IL-21R-deficient mice, cyclin D3 expression analysis, GC B cell light/dark zone flow cytometric analysis, immunization-induced and spontaneous autoimmune GC models\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined molecular mechanism (cyclin D3, Foxo1) and cellular phenotype, multiple GC models, single lab with orthogonal methods\",\n      \"pmids\": [\"37466652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"IL-21 secreted by intrathyroidal TFH and TPH cells drives clonally expanded cytotoxic CXCR6+CD8+ T cells in ICI-thyroiditis. IL-21 treatment of human CD8+ T cells upregulates IFN-γ, granzyme B, and CXCR6. Genetic deletion of IL-21 signaling in mice protects from thyroid immune infiltration after ICI treatment.\",\n      \"method\": \"Single-cell RNA sequencing of thyroid specimens, in vitro CD8+ T cell stimulation with IL-21, IL-21 genetic KO mouse model of IRAEs, immunohistochemistry\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — scRNA-seq defining cell populations, in vitro mechanistic validation, in vivo genetic KO confirmation, orthogonal human and mouse data\",\n      \"pmids\": [\"37196065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"IL-21 induces pyroptosis of Treg cells via activation of the Akt-mTOR-NLRP3-caspase 1 signaling axis in eosinophilic chronic rhinosinusitis. Akt-mTOR inhibition prevents IL-21-induced pyroptosis in human and mouse Treg cells. Blocking IL-21/IL-21R signaling reduces eosinophil numbers and increases Treg cell percentage in ECRS mice.\",\n      \"method\": \"Western blot analysis of pyroptosis markers, electron microscopy of pyroptotic cells, Akt-mTOR inhibitor treatment, IL-21/IL-21R neutralization in mouse model, flow cytometry\",\n      \"journal\": \"The Journal of allergy and clinical immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — defined signaling pathway with inhibitor validation, morphological evidence of pyroptosis, in vivo neutralization model, multiple orthogonal methods\",\n      \"pmids\": [\"37164271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"IL-21 promotes intestinal IgA class switch recombination and IgA production through TGFβ1-dependent mechanisms. IL-21 combined with retinoic acid induces IgA+ B cell development and drives autocrine TGFβ1 production to initiate IgA CSR. IL-21 also promotes intestinal B cell homing through α4β7 expression.\",\n      \"method\": \"Il17- and Il21-deficient mice, T cell reconstitution of TCRβxδ−/− mice with antigen-specific Th17 cells, IL-21 neutralization, B cell IgA CSR assays\",\n      \"journal\": \"Mucosal immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with defined cellular mechanism, neutralization in T cell reconstitution model, single lab with multiple methods\",\n      \"pmids\": [\"25586558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Histone deacetylase inhibitors (HDACi) combined with IL-21 reprogram differentiated human effector CD8+ T cells to central memory-like T cells. HDACi increases H3 acetylation and chromatin accessibility at the CD28 promoter, enabling IL-21-mediated pSTAT3 binding to the CD28 locus and subsequent upregulation of CD28 and CD62L. Reprogrammed cells show stable memory transcriptional signature (Lef1, Tcf7).\",\n      \"method\": \"ChIP for H3 acetylation and STAT3 binding at CD28 promoter (ATAC-seq for chromatin accessibility), flow cytometry for CD28/CD62L surface markers, functional proliferation assays\",\n      \"journal\": \"Cancer immunology research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP and chromatin accessibility data establishing mechanism, pSTAT3 binding validation, single lab\",\n      \"pmids\": [\"32213626\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"IL-21 is a pleiotropic type I cytokine produced primarily by CD4+ T cells (including Tfh and Th17 cells) and NKT cells that signals through a heterodimeric IL-21R/γc receptor complex to activate JAK/STAT pathways (principally STAT3, with opposing regulatory input from STAT1), driving B cell germinal center reactions (via Bcl-6 maintenance, cyclin D3-dependent dark zone cycling, and heparan sulfate-regulated signal strength), plasma cell differentiation, Th17 cell development (as an autocrine amplifier via STAT3→IL-21→RORγt), NK cell maturation, and direct Treg apoptosis through Bcl-2 family suppression and Akt-mTOR-NLRP3-caspase 1 pyroptosis, while its own transcription is regulated by c-Rel binding to its proximal promoter, STAT3-dependent long-range chromatin looping, NR2F6-mediated repression, and c-Maf SUMOylation status controlling CBP/p300-mediated histone acetylation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"IL-21 is a pleiotropic CD4+ T cell-derived cytokine that orchestrates B cell humoral immunity, T cell effector and memory programs, and immune regulation, signaling through the IL-21R to activate JAK/STAT pathways [#4, #9]. Loss-of-function mutation in its receptor causes a primary immunodeficiency, with aberrant IL-21R trafficking abrogating ligand binding and defective STAT1/STAT3/STAT5 phosphorylation that impairs B cell proliferation, class-switching, T cell cytokine production, and NK cytotoxicity [#4]. In B cells, IL-21 acts cell-intrinsically to maintain germinal center reactions: it sustains Bcl-6 expression by blocking BCR-driven proteasomal degradation (cooperatively with IL-4), accelerates cell cycle entry through AKT/S6 signaling, and tunes dark-zone selection via cyclin D3 and Foxo1, while human plasma cell differentiation requires B cell-intrinsic STAT3 [#1, #2, #17, #25, #26]. The strength of this B cell signal is set extracellularly by heparan sulfate N-sulfation, which is downregulated in GC B cells to desensitize them and upregulated in antibody-secreting cell precursors [#24]. In T cells, IL-21 is both an effector and a self-amplifying autocrine signal—IL-6/STAT3 induces IL-21, which feeds back via STAT3 recruitment to its promoter and STAT3/NFAT-dependent long-range enhancer looping to drive Th17 differentiation and suppress Foxp3 [#0, #3, #21]. IL-21 also restrains regulatory T cells, directly limiting Treg expansion and triggering Treg death via Bcl-2 family suppression and an Akt-mTOR-NLRP3-caspase-1 pyroptosis axis, and promotes CD8+ T cell stemness through metabolic quiescence dependent on oxidative phosphorylation [#10, #12, #28, #11]. IL-21 transcription is gated by activating inputs (c-Rel and SUMO-state-dependent c-Maf controlling Daxx/HDAC2 versus CBP/p300 occupancy) and repressive inputs (NR2F6 binding that is released during Tfh differentiation) [#8, #22, #23]. These activities make IL-21 a driver of autoimmune and inflammatory disease in models of EAE, type 1 diabetes, Th2/helminth pathology, and immune-checkpoint-induced thyroiditis [#0, #7, #6, #27].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established that IL-21 transcription is inducible by interferon signaling while IL-21R is reciprocally downregulated, defining an early layer of cross-cytokine control of the IL-21 axis.\",\n      \"evidence\": \"EMSA/promoter analysis and STAT3 phosphorylation in human NK and T cells\",\n      \"pmids\": [\"15178704\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GAS element occupancy shown by EMSA not chromatin-context ChIP\", \"Functional consequence of receptor downregulation on B cell output not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed IL-21 reshapes innate and Th2 effector function—suppressing NKG2D-dependent NK cytotoxicity via DAP10 while augmenting macrophage IL-4R/IL-13R responsiveness—broadening its role beyond adaptive immunity.\",\n      \"evidence\": \"DAP10 luciferase reporter and cytotoxicity/degranulation assays in human NK/CD8 cells; IL-21R-KO mice in helminth infection\",\n      \"pmids\": [\"16424177\", \"16778988\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcription factors driving DAP10 repression not identified\", \"Mechanism of IL-4R/IL-13R upregulation downstream of IL-21R unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified IL-21 as an autocrine cytokine necessary and sufficient for Th17 differentiation, placing it downstream of IL-6/STAT3 and explaining its role in autoimmune EAE.\",\n      \"evidence\": \"IL-21-deficient mice, STAT3/RORγt pathway analysis, EAE model\",\n      \"pmids\": [\"17581589\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve chromatin/promoter basis of IL-21 induction\", \"Relative contribution of autocrine vs paracrine IL-21 in vivo not quantified\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the molecular basis of IL-21 self-amplification by showing STAT3 is recruited to the IL-21 promoter to drive an autocrine transcriptional loop in human T cells.\",\n      \"evidence\": \"Promoter ChIP, STAT3 inhibition and siRNA with cytokine readout in human T cells\",\n      \"pmids\": [\"18209077\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Distal regulatory elements not yet examined\", \"Stoichiometry/kinetics of the feedback loop not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated IL-21R signaling is required for type 1 diabetes pathogenesis, linking the cytokine to organ-specific autoimmunity via Th17 expansion and Reg gene suppression.\",\n      \"evidence\": \"IL-21R-KO NOD mice with glucose monitoring, histology, and Reg gene quantification\",\n      \"pmids\": [\"18779574\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular target of IL-21 driving islet infiltration not isolated\", \"Mechanism connecting IL-21 to Reg gene levels unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed context-dependent IL-21 effects on transformed lymphocytes—apoptosis in follicular lymphoma versus pro-growth JAK3/STAT3 signaling in ALK+ ALCL and Burkitt lines.\",\n      \"evidence\": \"Caspase/mitochondrial assays in lymphoma lines; recombinant IL-21 and IL-21R siRNA with JAK3/STAT3 readout\",\n      \"pmids\": [\"17624663\", \"19608866\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Determinants of pro-apoptotic vs pro-growth outcome not defined\", \"Cell-line findings not validated in primary tumors in these studies\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Established IL-21 as a B cell-intrinsic regulator of the germinal center via Bcl-6 maintenance and showed human plasma cell differentiation strictly requires B cell-intrinsic STAT3.\",\n      \"evidence\": \"IL-21R-deficient bone marrow chimeras with immunization; human STAT1/STAT3 loss-of-function patient B cells\",\n      \"pmids\": [\"20142430\", \"20048285\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How IL-21/STAT3 sustains Bcl-6 mechanistically not resolved here\", \"STAT5 contribution to B cell program not addressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified c-Rel as a direct transcriptional activator of IL-21 in T cells and dissociated IL-21's role in Tfh formation from GC B cell development by rescue.\",\n      \"evidence\": \"c-Rel KO mice, promoter ChIP, IL-21 protein rescue, flow cytometry\",\n      \"pmids\": [\"20639489\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay of c-Rel with STAT3 at the locus not defined\", \"Why IL-21 rescues Tfh but not GC B cells in rel-/- not explained\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed IL-21 cell-intrinsically restrains Treg expansion and that this restraint is required for effective antiviral CD8 responses, framing IL-21 as a suppressor of immune regulation.\",\n      \"evidence\": \"IL-21R-KO mice in chronic LCMV with Treg depletion and IL-2 complex experiments\",\n      \"pmids\": [\"23696736\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism limiting Treg proliferation not defined here\", \"Direct vs indirect effect on CD8 responses not fully separated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Connected IL-21 to autoimmunity through SUMO-dependent c-Maf/NR4A2 regulatory inputs and to malignant B cell proliferation in CLL, expanding both transcriptional control and disease relevance.\",\n      \"evidence\": \"NR4A2 siRNA with IL-21 rescue and EAE; CD40L+IL-21 co-culture of CLL cells with gene signature and patient LN detection\",\n      \"pmids\": [\"23437182\", \"24014238\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"NR4A2 mechanism on IL-21 locus indirect\", \"CLL signature causal drivers not dissected\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Resolved that STAT1 and STAT3 exert opposing, non-redundant control of IL-21-driven gene programs in CD4+ T cells, including Tbx21/Ifng and in vivo antiviral outcomes.\",\n      \"evidence\": \"Stat1- and Stat3-deficient mice with RNA-Seq, chronic LCMV, and human patients with distinct STAT defects\",\n      \"pmids\": [\"26170288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How STAT1/STAT3 balance is set per cell type unresolved\", \"Direct target genes of each STAT not all mapped\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified Btk as an amplifier of IL-21 signaling controlling nuclear STAT1 phosphorylation in B cells, and linked IL-21 to intestinal IgA via TGFβ1-dependent class switching.\",\n      \"evidence\": \"Btk inhibitor with subcellular STAT1 fractionation in B cell line; Il21-deficient mice and Th17 reconstitution for IgA CSR\",\n      \"pmids\": [\"25724205\", \"25586558\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Btk's selectivity for nuclear vs cytoplasmic STAT1 mechanistically unclear\", \"Direct vs autocrine-TGFβ1 contributions to IgA not fully separated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined IL-21's metabolic and epigenetic logic—driving OXPHOS-dependent CD8 stemness, NK ADCC enhancement, and a STAT3/NFAT-dependent long-range enhancer loop controlling its own expression.\",\n      \"evidence\": \"Ldha deletion and metabolic profiling with adoptive transfer; NK ADCC/ERK/STAT1 assays with xenografts; 3C/4C chromatin conformation with STAT3/NFAT ChIP\",\n      \"pmids\": [\"32123114\", \"27435400\", \"27067007\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the distal enhancer is silenced in Tregs only partly defined\", \"Transcription-factor circuitry coupling metabolism to stemness not fully mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Showed IL-21 transcription is epigenetically gated by c-Maf SUMOylation state, which switches the locus between Daxx/HDAC2 repression and CBP/p300-mediated histone acetylation, driving diabetogenic extrafollicular help.\",\n      \"evidence\": \"Transgenic NOD mice with SUMO-mutant c-Maf, ChIP at Il21 promoter, CBP/p300 inhibitor\",\n      \"pmids\": [\"30059018\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals controlling c-Maf SUMOylation not defined\", \"Interaction with STAT3/c-Rel inputs at the locus unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established active repression and apoptosis arms of the axis: NR2F6 directly silences Il21 in resting T cells until Tfh differentiation, while IL-21 kills Foxp3+ Tregs via Bcl-2 family suppression to amplify Th2 inflammation.\",\n      \"evidence\": \"NR2F6 ChIP and Nr2f6-KO mice with IL-21R-blockade rescue; mixed chimeras and competitive transfer with Bcl-2 family apoptosis analysis\",\n      \"pmids\": [\"31509749\", \"30654048\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal that releases NR2F6 from the locus during Tfh differentiation not identified\", \"Bcl-2 family target(s) most responsible for Treg death not pinpointed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated IL-21 can reprogram differentiated effector CD8 T cells toward central-memory states when chromatin at the CD28 locus is opened, with pSTAT3 binding driving CD28/CD62L re-expression.\",\n      \"evidence\": \"HDACi plus IL-21 with ChIP/ATAC at CD28, pSTAT3 binding, and memory transcriptional signatures\",\n      \"pmids\": [\"32213626\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stability of reprogrammed state in vivo not established here\", \"Genome-wide pSTAT3 targets in reprogramming not mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Refined IL-21's germinal-center mechanism through cell-cycle and signal-strength control—cyclin D3/Foxo1-tuned dark-zone entry and heparan-sulfate-gated IL-21 bioavailability—and extended its pathogenic role to checkpoint-induced thyroiditis and Treg pyroptosis in chronic rhinosinusitis.\",\n      \"evidence\": \"IL-21R-KO GC analyses with cyclin D3/Foxo1; Ndst1-KO B cells with HS biochemistry; scRNA-seq plus IL-21-KO ICI-thyroiditis model; pyroptosis markers and Akt-mTOR-NLRP3 inhibition in ECRS\",\n      \"pmids\": [\"37466652\", \"36800411\", \"37196065\", \"37164271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Foxo1 is regulated by IL-21 signaling not fully defined\", \"Connection between HS desensitization and downstream STAT output not quantified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple transcriptional inputs (c-Rel, c-Maf, NR2F6, STAT3/NFAT enhancer looping) and the STAT1/STAT3 balance are integrated to set IL-21 dose and downstream program in each cell type remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking locus regulation to per-cell output\", \"Quantitative rules for IL-21 signal strength across receiving cell types not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [4, 24]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [4, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [1, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 1, 4, 9]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 9, 20]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [12, 19, 28]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"IL21R\", \"STAT3\", \"STAT1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}